What are the advanced treatment methods for lung squamous cell carcinoma?

The treatment of lung squamous cell carcinoma adopts different treatment methods according to different pathological and clinical processes. Clinical application of comprehensive treatment measures. Surgery, radiotherapy, interventional radiotherapy, chemotherapy, immunotherapy and traditional drug therapy are commonly used in clinic. Surgical treatment: Surgical treatment is the main treatment for lung squamous cell carcinoma. The specific scope and mode of operation should be determined according to the stage, malignant degree and pathological type of the tumor, as well as the size and location of the tumor and whether it involves adjacent organs. 2, radiotherapy: lung radiotherapy is mostly performed before and after surgery. Palliative radiotherapy can also achieve certain results for cases with advanced illness, loss of surgery opportunities or refusal of surgery and postoperative recurrence. 3. Interventional radiotherapy: Interventional radiotherapy refers to the use of radiology technology to directly inject drugs into the blood supply vessels of tumors through catheters, thus killing tumor cells. For patients with stage II-IV lung squamous cell carcinoma, this method can also be used to reduce the tumor focus, improve the surgical resection rate and reduce the recurrence rate. 4. Chemotherapy: Chemotherapy for lung squamous cell carcinoma includes intrapulmonary infusion chemotherapy, systemic chemotherapy and arterial infusion chemotherapy. (1) intrapulmonary perfusion chemotherapy is suitable for patients at all stages, especially for superficial tumors at stage 0-I, but it can't play a good role in treating other deep infiltration lesions, but it still has therapeutic effect on superficial lesions. (2) Systemic combined chemotherapy can improve the resection rate and comprehensive treatment effect of lung squamous cell carcinoma. 5. Immunotherapy: Transitional cell carcinoma of lung squamous cell carcinoma has antigenicity, and the impaired immune function of patients is closely related to tumor staging, grading and vascular lymphatic spread. Therefore, the disease is suitable for immunotherapy. 6. Chinese medicine treatment: Although Chinese medicine is effective in treating patients with lung squamous cell carcinoma, it has little effect, and it takes a long time to see the effect, but the patient's condition develops rapidly, so the treatment at this time is urgent. A large number of clinical practices have proved that high-dose radiotherapy and chemotherapy for patients in the middle and late stage, or re-chemotherapy for drug-resistant patients, can only lead to weaker life and accelerate the death of patients. Clinically, it is often seen that the death of patients is not caused by cancer itself, but by unscientific and inappropriate lethal treatment. For example, bone cancer died of liver failure such as ascites and jaundice after repeated interventions; Pleural effusion died of respiratory failure after chemotherapy for lung cancer; After chemotherapy for gastric cancer and intestinal cancer, nausea and vomiting make patients more tired and die. Leukocyte decline, patients died of infection, etc. For advanced cancer, it can relieve pain, improve the quality of life, control the disease, "strive for progress steadily" and obtain "long-term survival with tumor". Radiochemotherapy combined with biological immunotherapy is "treating tumors with your own cells", so it will not produce rejection and side effects, and it is safe. In the process of treatment, the treatment method of "blood collection-infusion" is adopted, which is easy and painless, and the purpose of treating tumors is realized in "infusion". Biological immunotherapy is the latest tumor treatment technology superior to surgery, radiotherapy and chemotherapy, and it is also the most mature and widely used tumor biotherapy technology at present, which can directly kill cancer cells, prevent recurrence and metastasis, improve self-immunity and improve quality of life. Biological immunotherapy of tumor, by extracting patients' peripheral blood, using American patent technology to carry out antigen-loaded culture in vitro, and reinfusion into patients with lung squamous cell carcinoma, activates and proliferates tumor-killing and immune cells in large quantities, which is more than 5 times more effective than other cell therapies. While accurately killing and removing residual and tiny tumor lesions, it can enhance the body's immunity and prevent the spread and recurrence of cancer cells. While DC-CIK cells kill tumor cells, patients can feel different degrees of symptom relief. At the same time, cancer. The emergence of biotherapy makes up for the deficiency of surgery, radiotherapy and chemotherapy. It can rebuild human immune system and repair the damage caused by surgery, radiotherapy and chemotherapy. At the same time, it can improve the sensitivity of lung squamous cell carcinoma patients to radiotherapy and chemotherapy, consolidate the therapeutic effect, effectively inhibit tumor cells and prevent their recurrence and metastasis. Its appearance brings life hope to more patients with lung squamous cell carcinoma metastasis, and makes the life of patients with lung squamous cell carcinoma continue. Recommended reading: Beijing hospital for lung cancer, Beijing better liver cancer hospital, Beijing better esophageal cancer hospital.